New CME for Oncologists
Wondering which chemotherapy is the most ideal and beneficial for your patients?
The Johns Hopkins School of Medicine is giving you the opportunity to find the answers you have been searching for in their new CME activity,
â€œTodayâ€™s Patient in Non-Small-Cell Lung Cancer: Does Histology Make a Difference?â€
This free, online CME activity will allow participants to gain knowledge and competence with respect to the role of histology in determining the type of chemotherapy that is used, the appropriate maintenance therapies to use in treatment plans for patients with NSCLC, and how to develop strategies to individualize therapy based on histology.
Visit their website to let the Johns Hopkins University School of Medicine help you find the answers.
Publication of an advertisement on this site is not to be considered an endorsement or approval by the Texas Medical Association of the product or service involved.
To report inappropriate ads, please email: Classifieds@texmed.org